As of Jan 20
| +0.01 / +0.85%|
The 3 analysts offering 12-month price forecasts for Alimera Sciences Inc have a median target of 3.00, with a high estimate of 10.00 and a low estimate of 3.00. The median estimate represents a +154.24% increase from the last price of 1.18.
The current consensus among 3 polled investment analysts is to Buy stock in Alimera Sciences Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.